Home
1
News
2
News list
3
Summary: Jan.-June, 20224
奈聯生技元件科技公司 300 新竹市東區光復路二段101號國立清華大學創新育成大樓818室
Summary: Jan.-June, 20221. Novel Plasmonic-based SERS and small RNA technologies (PSSR), that enable crossing the “only one analyte” barrier. 2. Potential applications of PSSR technology in emerging biomedical areas:   (1). RNA2D3D studies   (2). Aptamers research   (3). Exosome biomarkers / Liquid biopsy   (4). CDMO/ADC businesses   (5). Novel small RNA discovery   (6). HTS screening for RNA targeting small molecules therapeutics candidates http://www.nbdinc.com.tw/hot_433814.html Summary: Jan.-June, 2022 2022-06-28 2023-06-28
奈聯生技元件科技公司 300 新竹市東區光復路二段101號國立清華大學創新育成大樓818室 http://www.nbdinc.com.tw/hot_433814.html
奈聯生技元件科技公司 300 新竹市東區光復路二段101號國立清華大學創新育成大樓818室 http://www.nbdinc.com.tw/hot_433814.html
https://schema.org/EventMovedOnline https://schema.org/OfflineEventAttendanceMode
2022-06-28 http://schema.org/InStock TWD 0 http://www.nbdinc.com.tw/hot_433814.html

Summary: Jan.-June, 2022

1. Novel Plasmonic-based SERS and small RNA technologies (PSSR), that enable crossing the “only one analyte” barrier.

2. Potential applications of PSSR technology in emerging biomedical areas:
   (1). RNA2D3D studies
   (2). Aptamers research
   (3). Exosome biomarkers / Liquid biopsy
   (4). CDMO/ADC businesses
   (5). Novel small RNA discovery
   (6). HTS screening for RNA targeting small molecules therapeutics candidates